Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L; LEAD-6 Study Group.

Lancet. 2009 Jul 4;374(9683):39-47. doi: 10.1016/S0140-6736(09)60659-0. Epub 2009 Jun 8.

PMID:
19515413
2.

Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.

Bergenstal R, Lewin A, Bailey T, Chang D, Gylvin T, Roberts V; NovoLog Mix-vs.-Exenatide Study Group.

Curr Med Res Opin. 2009 Jan;25(1):65-75. doi: 10.1185/03007990802597951 .

PMID:
19210140
3.
4.

Apparent increase in type I 5'-deiodinase activity induced by antiepileptic medication in mentally retarded subjects.

Premachandra BN, Radparvar A, Burman K, Williams IK.

Horm Res. 2002;58(6):273-8.

PMID:
12446990
5.
6.

Glyburide-induced hepatitis.

Goodman RC, Dean PJ, Radparvar A, Kitabchi AE.

Ann Intern Med. 1987 Jun;106(6):837-9.

PMID:
3107448

Supplemental Content

Loading ...
Support Center